supply of expendable medical items - lignocaine hci 2% (without adrenaline) 30 ml inj (suitable for ophthalmic use also), phytomenadione (vit k) 10 mg/0.5 ml inj, common cold tab (antihistiminics + paracetamol 500 mg without pseudoephedrine), diclofenac sodium 50mg tab, ibuprofen syrup 100 mg/5ml bott of 50 ml, pheniramine maleate inj 22.75 mg per ml amp of 2 ml, clonazepam 2 mg tab, ivermectin tab 6mg, diclofenac suppositories 25 mg, tab mercaptopurine 50mg, diltiazem (controlled release) 90mg

Ministry Of Defence has invited bids for the supply of expendable medical items - lignocaine hci 2% (without adrenaline) 30 ml inj (suitable for ophthalmic use also), phytomenadione (vit k) 10 mg/0.5 ml inj, common cold tab (antihistiminics + paracetamol 500 mg without pseudoephedrine), diclofenac sodium 50mg tab, ibuprofen syrup 100 mg/5ml bott of 50 ml, pheniramine maleate inj 22.75 mg per ml amp of 2 ml, clonazepam 2 mg tab, ivermectin tab 6mg, diclofenac suppositories 25 mg, tab mercaptopurine 50mg, diltiazem (controlled release) 90mg tab, clonidine 100 mcg tab, hydrochlorothiazide 25mg, antiseptic mouthwash containing sodium floride and triclosan, triamcinalone acetonide 0.1% for oral use, tube of 5 gm, clindamycin phosphate 1% topical gel tube of 10 gm, silver sulphadiazine 1% jar of 500 gms, acetazolamide 0.25g tab, antacid (chewable) containing dried aluminium hydroxide ip 250mg mag hydroxide nf 250mg methyl polysiloxane 50mg tab, tab ranitidine 150 mg, carbimazole 5 mg tab, tab sevelamer 400 mg, pancreatin microspheres 150 mg and above cap, betahistine dihydrochloride 8mg tab, cinnarizine 25 mg tab. The estimated project cost is ₹0.03 Cr, with an EMD of ₹0 Cr. Interested bidders can submit applications until 21 September 2026, with the technical opening scheduled for 22 September 2026.